Guillain-Barre Syndrome synonyms

Guillain-Barré Syndrome (GBS) is most commonly referred to by its eponymous name, though it is also clinically classified as Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP).

Common Synonyms and Historical Nomenclature

While Guillain-Barré Syndrome is the standard medical term, you may encounter several historical names in older literature, including Landry's paralysis, Landry-Guillain-Barré syndrome, and acute idiopathic polyneuritis. These terms reflect the evolution of our understanding of the condition, which was first described by French physicians Georges Guillain, Jean Alexandre Barré, and André Strohl in 1916. The term "Landry’s paralysis" was historically used to describe the ascending nature of the weakness, but it is rarely used today as it lacks the specificity of the modern diagnostic criteria for Guillain-Barré Syndrome.

Classification and Official Terminology

In international medical coding and classification systems, the condition is categorized based on its clinical presentation and underlying pathology. According to the International Classification of Diseases (ICD-11), it is indexed under 8A00 (Guillain-Barré syndrome). In the Online Mendelian Inheritance in Man (OMIM) database, it is referenced as #139393. Orphanet, the reference portal for rare diseases, uses the umbrella term Guillain-Barré Syndrome while recognizing distinct subtypes such as Miller Fisher syndrome, which is a rare variant characterized by ophthalmoplegia, ataxia, and areflexia.

Why Multiple Names Exist

The existence of multiple names for Guillain-Barré Syndrome is primarily a result of historical medical practices, where conditions were often named after the clinicians who first identified them. As clinical research advanced, the focus shifted from eponymous names to descriptive, pathological names like Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP). Today, medical professionals overwhelmingly prefer the term Guillain-Barré Syndrome because it is universally recognized by neurologists worldwide, ensuring clarity in emergency settings where rapid diagnosis is vital for initiating life-saving interventions like IVIG or plasmapheresis.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a neurologist or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Guillain-Barré syndrome


• Orphanet: Guillain-Barré syndrome (ORPHA:388)


• OMIM (Online Mendelian Inheritance in Man): Entry #139393